Mastek is currently trading at Rs. 2845.80, up by 5.05 points or 0.18% from its previous closing of Rs. 2840.75 on the BSE.
The scrip opened at Rs. 2851.05 and has touched a high and low of Rs. 2894.80 and Rs. 2820.00 respectively. So far 1643 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3147.00 on 16-Feb-2024 and a 52 week low of Rs. 2105.95 on 26-Oct-2023.
Last one week high and low of the scrip stood at Rs. 3058.00 and Rs. 2820.00 respectively. The current market cap of the company is Rs. 8770.18 crore.
The promoters holding in the company stood at 36.23%, while Institutions and Non-Institutions held 18.54% and 45.22% respectively.
Mastek has entered into strategic partnership with Innovaccer, a leading healthcare AI company to drive better outcomes at lower costs and meet contracted performance targets. This collaboration will help recalibrate the company’s extensive healthcare focus by integrating Innovaccer’s expertise in data, customer experience, AI, and analytics, enhancing service offerings, and delivering significant impact through a focused value-based care model.
With healthcare as a key strategic focus, Mastek and Innovaccer aim to deliver holistic solutions to healthcare organizations. This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences, improve health outcomes, and improve the overall quality of care, all while ensuring affordability for patients.
Innovaccer’s AI-powered Health Experience Platform (HXP) unifies data from diverse sources, including electronic health records (EHRs), customer relationship management (CRM) systems, and enterprise data warehouses (EDWs). By integrating this platform with the company’s Healthcloud capabilities, healthcare organizations will gain access to predictive and actionable insights, helping them enhance decision-making and patient outcomes.
Mastek together with its subsidiaries, provides enterprise technology solutions and platforms for insurance, government, and financial services organizations worldwide.
| Company Name | CMP |
|---|---|
| TCS | 4167.95 |
| Infosys | 1916.55 |
| HCL Tech. | 1891.65 |
| Wipro | 309.10 |
| Tech Mahindra | 1711.80 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Limited to the first 10 users today!
Practical Stock Investing Hand Book
By - Raymond Moses
Founder of MoneyWorks4Me | Consultant | Trainer | Author | TEDx Speaker
Register & Get Instant Access!Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
